These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22305488)

  • 1. A case of repeated brief psychotic episodes secondary to discontinuation of non-prescription estrogen replacement therapy.
    Findley JC; Joshi KG
    Psychosomatics; 2012; 53(3):285-8. PubMed ID: 22305488
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of first-onset psychosis and repeated relapses secondary to discontinuation of non-prescription estrogen replacement therapy in a transgendered female.
    Moffitt O; Findley JC
    Gynecol Endocrinol; 2016 Oct; 32(10):796-798. PubMed ID: 27426632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogens--pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation--Estring.
    Johnston A
    Acta Obstet Gynecol Scand Suppl; 1996; 163():16-25. PubMed ID: 8916471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
    Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
    Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?].
    Lippert TH; Seeger H; Mueck AO
    Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen therapy and carcinoma of the endometrium (author's transl)].
    Völker W; Kannengiesser U; Majewski A; Vasterling HW
    Geburtshilfe Frauenheilkd; 1978 Sep; 38(9):735-43. PubMed ID: 210085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia.
    Baptista T; Beaulieu S
    Acta Psychiatr Scand; 2002 Jun; 105(6):473-4; author reply 474. PubMed ID: 12059854
    [No Abstract]   [Full Text] [Related]  

  • 11. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute psychosis following phenelzine discontinuation.
    Liskin B; Roose SP; Walsh BT; Jackson WK
    J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy].
    Tanaka K; Honjo H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():696-700. PubMed ID: 11347156
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoma of the breast during estrogen replacement therapy.
    Fechner RE
    Cancer; 1972 Mar; 29(3):566-73. PubMed ID: 4334234
    [No Abstract]   [Full Text] [Related]  

  • 16. [Climacteric in the woman].
    Lauritzen C
    Med Klin; 1971 Sep; 66(38):1255-61. PubMed ID: 4938827
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioidentical hormones: panacea for menopausal hormonal therapy or bio-beware?
    Hansen K
    S D Med; 2008 Jul; 61(7):244-5. PubMed ID: 18717291
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen replacement and migraine.
    MacGregor EA
    Maturitas; 2009 May; 63(1):51-5. PubMed ID: 19375252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
    Easton BT
    J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
    [No Abstract]   [Full Text] [Related]  

  • 20. A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report.
    Huber TJ; Nickel V; Tröger M; Schneider U; Husstedt H; Emrich HM
    Neuropsychobiology; 1999; 40(2):75-7. PubMed ID: 10474061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.